Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

NIMODIPINE

NIMODIPINE

Standard Dose
30MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview NIMODIPINE is listed in Drugs@FDA under application 201832 (ANDA).

Marketing status: Discontinued Active ingredient NIMODIPINE Form and strength CAPSULE;ORAL - 30MG Sponsor SOFGEN PHARMS Submission history Latest submission status date: 2015-07-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview NIMODIPINE is listed in Drugs@FDA under application 201832 (ANDA). Marketing status: Discontinued Active ingredient NIMODIPINE Form and strength CAPSULE;ORAL - 30MG Sponsor SOFGEN PHARMS Submission history Latest submission status date: 2015-07-24 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.